News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
A new website is now available to find technologies related to rare diseases or conditions across 30 of the Clinical Translation Science Award (CTSA) institutions and NIH. The CTSA institutions are funded by NIH as part of a program designed to spur the transformation of clinical and translational
The Office of Intramural Research, Office of the Director, NIH, invites you to the seventh annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. The lecture will be held on Thursday, November 15, 2012, at 10:00 AM in the Masur Auditorium, Building 10, NIH
The NIH Office of Technology Transfer (OTT) has signed a new Partnership Intermediary Agreement (PIA) with BioHealth Innovation (BHI), a new regional private-public partnership in Maryland focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding